Showing 161 - 180 results of 741 for search '"Leukemia"', query time: 0.07s Refine Results
  1. 161

    Unveiling the omics tapestry of B-acute lymphoblastic leukemia: bridging genomics, metabolomics, and immunomics by Yin Le, Shicong Zhu, Hongling Peng, Zhihua Wang

    Published 2025-01-01
    “…Abstract Acute B-lymphoblastic leukemia (B-ALL) is a highly heterogeneous hematologic malignancy, characterized by significant molecular differences among patients as the disease progresses. …”
    Get full text
    Article
  2. 162

    IgE Plasma Cell Leukemia Harboring t(11;14) and 1q Amplification by Wataru Nakahara, Takahito Ogawa, Hitomi Matsunaga, Yuki Iwasa, Momoka Horita, Mako Ikeda, Mizuki Asako, Sadaharu Iio, Yuki Iwama, Kazumasa Oka, Shuji Ueda

    Published 2023-01-01
    “…Here, we report a case of IgE primary plasma cell leukemia with extramedullary lesions of the liver, stomach, and lymph nodes. …”
    Get full text
    Article
  3. 163

    Association of killer immunoglobulin-like receptor genotypes and haplotypes with acute lymphoblastic leukemia risk by Jameel Al-Tamimi, Suliman Alomar, Ali Aljuaimlani, Lamjed Mansour

    Published 2025-01-01
    “…This study aimed to investigate the relationships between KIR genotypes and haplotypes with acute lymphoblastic leukemia (ALL) in Saudi patients. Methods A total of 259 Saudi subjects including 145 cases of acute lymphoblastic leukemia (ALL) and 114 healthy controls living in Riyadh were genotyped for 16 KIR genes and the two HLA-C1 and -C2 allotypes using PCR-SSP genotyping method. …”
    Get full text
    Article
  4. 164

    Prolonged Pediatric Extracorporeal Membrane Oxygenation Support with Cardiopulmonary Failure in Juvenile Myelomonocytic Leukemia by Maris Bartkevics, Bert Hennig, Tayfun Gungor, Roland Ammann, Alexander Kadner

    Published 2020-01-01
    “…We report a case of a child survival after extracorporeal membrane oxygenation (ECMO) support of 25 days for cardiopulmonary failure and septic shock in the context of juvenile myelomonocytic leukemia (JMML). ECMO support is still a matter of debate for the management of septic patients with malignancy. …”
    Get full text
    Article
  5. 165

    Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation by Håkon Reikvam, Jørn Skavland, Stein-Erik Gullaksen, Randi Hovland, Tobias Gedde-Dahl, Øystein Bruserud, Bjørn Tore Gjertsen

    Published 2018-01-01
    “…Chronic myeloid leukemia (CML) is a myeloproliferative disorder in which neoplastic cells exhibit the Philadelphia chromosome and the related oncoprotein BCR-ABL1. …”
    Get full text
    Article
  6. 166
  7. 167

    Permanent Sensorineural Deafness in a Patient with Chronic Myelogenous Leukemia Secondary to Intracranial Hemorrhage by Sakshi Kapur, Michael Wax, Levin Miles, Adnan Hussain

    Published 2013-01-01
    “…The initial impression was chronic myelogenous leukemia with hyperleukocytosis, and patient was started on hydration, hydroxyurea, and allopurinol. …”
    Get full text
    Article
  8. 168
  9. 169
  10. 170

    How to use monoclonal antibody-based therapy in ALL by Erica Brivio, Sujith Samarasinghe

    Published 2025-06-01
    Subjects: “…Pediatric leukemia…”
    Get full text
    Article
  11. 171

    Nilotinib-Induced Dystonia and Cognitive Deficits in a Neurologically Normal Patient with Chronic Myeloid Leukemia by Justine Chan, Paarth Shah, Guillermo Moguel-Cobos

    Published 2019-01-01
    “…Nilotinib is a tyrosine kinase inhibitor used to treat patients with chronic myeloid leukemia (CML). This agent is also being studied in neurodegenerative disorders including Parkinson disease. …”
    Get full text
    Article
  12. 172
  13. 173

    Osteoblastic and Vascular Endothelial Niches, Their Control on Normal Hematopoietic Stem Cells, and Their Consequences on the Development of Leukemia by Bella S. Guerrouahen, Ibrahim Al-Hijji, Arash Rafii Tabrizi

    Published 2011-01-01
    “…And finally, we will review some data on the development of acute myeloid leukemia from a subpopulation called leukemia-initiating cells (LIC), and we will discuss on the emerging evidences supporting the influence of the microenvironment on chemotherapy resistance.…”
    Get full text
    Article
  14. 174

    A Unique Case of Relapsed B-Acute Lymphoblastic Leukemia/Lymphoma as an Isolated Omental Mass by Kanchan Kantekure, Furha Cossor, Kenneth B. Miller, Monika E. Pilichowska

    Published 2014-01-01
    “…B-acute lymphoblastic leukemia/lymphoma (B-ALL) is a neoplasm of precursor cells committed to the B-cell lineage. …”
    Get full text
    Article
  15. 175
  16. 176

    Unusual Presentation with Orbital Mass in a Child with Precursor B-Cell Acute Lymphoblastic Leukemia by Lalita Sathitsamitphong, Rungrote Natesirinilkul, Worawut Choeyprasert, Pimlak Charoenkwan

    Published 2019-01-01
    “…Orbital involvement is one of the extramedullary manifestations in acute leukemia. It is common in acute myeloid leukemia, but rare in acute lymphoblastic leukemia (ALL). …”
    Get full text
    Article
  17. 177

    An unveiling case of Nocardia pansinusitis in a patient with chronic lymphocytic leukemia: a case report by Maedeh Najafizadeh, Fatemeh Kourkinejad Gharaei, Reza Manouchehri Ardekani, Mahdi Rafiyan

    Published 2025-01-01
    “…Case presentation In this case report, we present, for the first time, a 55-year-old Iranian male patient diagnosed with chronic lymphocytic leukemia who was receiving chemotherapeutic drugs and developed a fever. …”
    Get full text
    Article
  18. 178
  19. 179

    MYST3/CREBBP Rearranged Acute Myeloid Leukemia after Adjuvant Chemotherapy for Breast Cancer by Arjun Gupta, Mrinal M. Patnaik, Harris V. Naina

    Published 2014-01-01
    “…Although rare, clinicians and patients must be aware that therapy related malignancies, specifically acute myeloid leukemia (AML), can occur as a complication of adjuvant chemotherapy for breast cancer. …”
    Get full text
    Article
  20. 180

    Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias by Alessandro Morotti, Giovanna Carrà, Cristina Panuzzo, Sabrina Crivellaro, Riccardo Taulli, Angelo Guerrasio, Giuseppe Saglio

    Published 2015-01-01
    “…BCR-ABL-mediated leukemias, either Chronic Myeloid Leukemia (CML) or Philadelphia positive Acute Lymphoblastic Leukemia (ALL), are the paradigm of targeted molecular therapy of cancer due to the impressive clinical responses obtained with BCR-ABL specific tyrosine kinase inhibitors (TKIs). …”
    Get full text
    Article